{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T17:10:03Z","timestamp":1690737003682},"reference-count":17,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"unspecified","delay-in-days":2588,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:sec id=\"S0317167100007320_abs1\"><jats:title><jats:italic><jats:bold>Background<\/jats:bold><\/jats:italic>:<\/jats:title><jats:p>Current Health Canada instructions for use of the dopamine agonists (DA), pramipexole and ropinirole, state that Parkinson's disease (PD) patients should be told not to drive. The objective was to assess neurologists' actual clinical practice concerning driving advice they give to PD patients starting a DA.<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100007320_abs2\"><jats:title><jats:italic><jats:bold>Methods<\/jats:bold><\/jats:italic>:<\/jats:title><jats:p>An online survey was created consisting of 4 items regarding demographics, 5 regarding PD and driving, and 9 regarding DA use and driving. The survey was distributed to 563 neurologists.<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100007320_abs3\"><jats:title><jats:italic><jats:bold>Results<\/jats:bold><\/jats:italic>:<\/jats:title><jats:p>In total 96 neurologists (17.9%) responded. 4.4% tell patients with PD not to drive, solely because they are taking a DA. Respondents assess the patient's tendency for excessive daytime sleepiness and sleep attacks after starting a DA more frequently than after starting other dopaminergic drugs (p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec id=\"S0317167100007320_abs4\"><jats:title><jats:italic><jats:bold>Discussion<\/jats:bold><\/jats:italic>:<\/jats:title><jats:p>A minor proportion of the clinicians responding to our survey advise PD patients not to drive, solely because they use a DA. Such being the case, we propose that current Health Canada guidelines need revision.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0317167100007320","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T15:27:21Z","timestamp":1418398041000},"page":"438-442","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Practice Regarding Dopamine-Agonist Use and Driving in Parkinson's Disease"],"prefix":"10.1017","volume":"34","author":[{"given":"R. M.A.","family":"de Bie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Miyasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. H.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"S0317167100007320_ref006","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0239-5"},{"key":"S0317167100007320_ref004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1212\/WNL.54.1.274","article-title":"Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole [letter].","volume":"54","author":"Weiner","year":"2000","journal-title":"Neurology."},{"key":"S0317167100007320_ref002","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.9.1908"},{"key":"S0317167100007320_ref008","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.42.5.458"},{"key":"S0317167100007320_ref011","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.4.455"},{"key":"S0317167100007320_ref005","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20958"},{"key":"S0317167100007320_ref015","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3932(89)90128-0"},{"key":"S0317167100007320_ref003","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.1.274"},{"key":"S0317167100007320_ref017","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38863.638194.AE"},{"key":"S0317167100007320_ref014","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.25.8.701"},{"key":"S0317167100007320_ref016","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F"},{"key":"S0317167100007320_ref009","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.3.460"},{"key":"S0317167100007320_ref012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/PL00022915","article-title":"ParkinsonCJN34_4prd.xml 8-Oct-2014 11:26:24a 3,081 S0317167100007241jxx.xml 7-Oct-2014 2:52:14p 5,929 S0317167100007253jed.xml 29-Oct-2014 4:08:52p 34,392 S0317167100007265jrv.xml 29-Oct-2014 4:09:26p 23,101 S031716712019;s disease and sleep.","volume":"247","author":"Clarenbach","year":"2000","journal-title":"J Neurol."},{"key":"S0317167100007320_ref013","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007770"},{"key":"S0317167100007320_ref010","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000233980.25978.9d"},{"key":"S0317167100007320_ref007","first-page":"1329","article-title":"Parkinsonism and driving fitness.","volume":"121","author":"Ritter","year":"1979","journal-title":"Munch Med Wochenschr."},{"key":"S0317167100007320_ref001","first-page":"3","article-title":"Antiparkinsonian drugs and \u201csleep attacks.\u201d","volume":"11","author":"Moller","year":"2001","journal-title":"Canadian ADR newsletter."}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100007320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T16:56:22Z","timestamp":1690736182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100007320\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0317167100007320"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100007320","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}